1.51908

LiChrospher^® 100 RP-18 endcapped (5 µm) HPLC Columns

L x I.D. 125 mm x 4 mm LiChroCART^™ HPLC cartridge, manuCART^™ holder required for use

• 别名: TM=["LiChrospher"] C18 TM=["LICHROCART"] cartridge for HPLC
• 分類程式碼代碼: 41115700
• NACRES: SB.52

属性

• product name: LiChrospher^® 100 RP-18 endcapped (5µm) LiChroCART^™ 125-4.6, suitable for HPLC
• 材料: stainless steel column
• agency: suitable for USP L1
• 產品線: LiChrospher^®
• 特點: endcapped
• 包裝: 1 ea of
• 標籤範圍: 21.6% Carbon loading
• 參數: 250 bar pressure; 60 °C max. temp.
• 技術: HPLC: suitable; mass spectrometry (MS): suitable (Low - Medium)
• 柱長度 × 內徑: 12.5 cm × 4.6 mm
• 表面積: 350 m²/g
• 基質: fully porous particle
• 基質活性組: C18 bonding phase
• 粒徑: 5 μm
• 孔徑: 100 Å pore size
• 工作pH值範圍: 2-7.5
• 分離技術: reversed phase
• 儲存溫度: no temp limit

说明

一般說明

HPLC cartridge

應用

• Liquid chromatographic determination of lumacaftor in the presence of ivacaftor and identification of five novel degradation products using high-performance liquid chromatography ion trap time-of-flight mass spectrometry: This study effectively utilizes the Ascentis^® Express F5, 2.7 μm HPLC column to analyze complex pharmaceutical mixtures and identify degradation products, demonstrating the column′s high-resolution capabilities and robust performance in pharmaceutical analysis (Özcan et al., 2023).


• Stability-indicating LC-MS/MS and LC-DAD methods for robust determination of tasimelteon and high resolution mass spectrometric identification of a novel degradation product: This research highlights the use of the Ascentis^® Express F5 HPLC column in developing stability-indicating methods for the analysis of tasimelteon, underscoring its crucial role in ensuring the quality and safety of pharmaceuticals through advanced analytical techniques (Özcan et al., 2020).

法律資訊

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany

LICHROCART is a trademark of Merck KGaA, Darmstadt, Germany

LiChrospher is a registered trademark of Merck KGaA, Darmstadt, Germany